Graham Capital Management, L.P. Exact Sciences Corp Transaction History
Graham Capital Management, L.P.
- $3.11 Billion
- Q2 2024
A detailed history of Graham Capital Management, L.P. transactions in Exact Sciences Corp stock. As of the latest transaction made, Graham Capital Management, L.P. holds 4,997 shares of EXAS stock, worth $265,990. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,997
Previous 11,091
54.95%
Holding current value
$265,990
Previous $765,000
72.42%
% of portfolio
0.01%
Previous 0.02%
Shares
6 transactions
Others Institutions Holding EXAS
# of Institutions
651Shares Held
166MCall Options Held
1.96MPut Options Held
1.41M-
Vanguard Group Inc Valley Forge, PA18.2MShares$967 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA16.5MShares$878 Million0.12% of portfolio
-
Wellington Management Group LLP Boston, MA14.8MShares$787 Million0.11% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$642 Million0.01% of portfolio
-
State Street Corp Boston, MA8.21MShares$437 Million0.02% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $9.42B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...